Home › NDC Lookup › RxCUI directory › RxCUI 1596023

Ferric citrate 1000 MG Oral Tablet [Auryxia] — RxCUI 1596023

RxNorm drug concept · Semantic branded drug
RxCUI 1596023 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1596023
Official nameFerric citrate 1000 MG Oral Tablet [Auryxia]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAuryxia 1000 MG Oral Tablet; Auryxia (iron) 210 MG Oral Tablet; Auryxia 1 GM (iron 210 MG) Oral Tablet
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)10,196 prescriptions · 37 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ferric Citrate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It depends on your situation. If you have chronic kidney disease and are on dialysis, it controls the phosphorus level in your blood. If you have chronic kidney disease but are not...
  • Take the tablets by mouth with meals, three times a day, as your prescriber directs. Swallow them whole. Don't chew or crush them, since that can discolor your mouth and teeth.
  • Dark or discolored stools are a common effect of this medicine and are expected. Diarrhea, constipation, nausea and stomach upset can also happen. Let your doctor know if digestive...
  • Many common medicines were tested and could be taken together. But doxycycline should be taken at least 1 hour before ferric citrate, and ciprofloxacin at least 2 hours before or a...
📖 Read our full Ferric Citrate guide →

🕸️ Concept Web — How Ferric citrate 1000 MG Oral Tablet [Auryxia] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ferric citrate 1000 MG Oral Tablet [Auryxia] RxCUI 1596023

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ferric citrate 1594675
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Auryxia 1596018
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ferric citrate Oral Tablet 1594679
    • Ferric citrate Oral Product 1594677
    • Ferric citrate Pill 1594678
    • Ferric citrate Oral Tablet [Auryxia] 1596020
    • Auryxia Oral Product 1596021
    • Auryxia Pill 1596022
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ferric citrate 1000 MG Oral Tablet SCD · 1594680
  • Ferric citrate 1000 MG SCDC · 1594676
  • Ferric citrate Oral Tablet SCDF · 1594679
  • Ferric citrate Oral Product SCDG · 1594677
  • Ferric citrate Pill SCDG · 1594678

Brand-Name Concepts

  • Ferric citrate 1000 MG [Auryxia] SBDC · 1596019
  • Ferric citrate Oral Tablet [Auryxia] SBDF · 1596020
  • Auryxia Oral Product SBDG · 1596021
  • Auryxia Pill SBDG · 1596022
  • Auryxia BN · 1596018

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1596023 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59922-0631-01 200 TABLET, FILM COATED in 1 BOTTLE (59922-631-01) Auryxia Akebia Therapeutics, Inc. 2014-09-17
Observed labelers: Akebia Therapeutics, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$7.4810
Range $7.4810–$7.4810 · middle 50% $7.4810–$7.4810 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.